Combined cCTA and TAVR Planning for Ruling Out Significant CAD: Added Value of ML-Based CT-FFR.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
03 2022
Historique:
received: 26 03 2021
revised: 07 09 2021
accepted: 10 09 2021
pubmed: 22 11 2021
medline: 28 4 2022
entrez: 21 11 2021
Statut: ppublish

Résumé

The purpose of this study was to analyze the ability of machine-learning (ML)-based computed tomography (CT)-derived fractional flow reserve (CT-FFR) to further improve the diagnostic performance of coronary CT angiography (cCTA) for ruling out significant coronary artery disease (CAD) during pre-transcatheter aortic valve replacement (TAVR) evaluation in patients with a high pre-test probability for CAD. CAD is a frequent comorbidity in patients undergoing TAVR. Current guidelines recommend its assessment before TAVR. If significant CAD can be excluded on cCTA, invasive coronary angiography (ICA) may be avoided. Although cCTA is a very sensitive test, it is limited by relatively low specificity and positive predictive value, particularly in high-risk patients. Overall, 460 patients (age 79.6 ± 7.4 years) undergoing pre-TAVR CT were included and examined with an electrocardiogram-gated CT scan of the heart and high-pitch scan of the vascular access route. Images were evaluated for significant CAD. Patients routinely underwent ICA (388/460), which was omitted at the discretion of the local Heart Team if CAD could be effectively ruled out on cCTA (72/460). CT examinations in which CAD could not be ruled out (CAD ML-based CT-FFR was successfully performed in 79.4% (216/272) of all CAD ML-based CT-FFR may further improve the diagnostic performance of cCTA by correctly reclassifying a considerable proportion of patients with morphological signs of obstructive CAD on cCTA during pre-TAVR evaluation. Thereby, CT-FFR has the potential to further reduce the need for ICA in this challenging elderly group of patients before TAVR.

Sections du résumé

OBJECTIVES
The purpose of this study was to analyze the ability of machine-learning (ML)-based computed tomography (CT)-derived fractional flow reserve (CT-FFR) to further improve the diagnostic performance of coronary CT angiography (cCTA) for ruling out significant coronary artery disease (CAD) during pre-transcatheter aortic valve replacement (TAVR) evaluation in patients with a high pre-test probability for CAD.
BACKGROUND
CAD is a frequent comorbidity in patients undergoing TAVR. Current guidelines recommend its assessment before TAVR. If significant CAD can be excluded on cCTA, invasive coronary angiography (ICA) may be avoided. Although cCTA is a very sensitive test, it is limited by relatively low specificity and positive predictive value, particularly in high-risk patients.
METHODS
Overall, 460 patients (age 79.6 ± 7.4 years) undergoing pre-TAVR CT were included and examined with an electrocardiogram-gated CT scan of the heart and high-pitch scan of the vascular access route. Images were evaluated for significant CAD. Patients routinely underwent ICA (388/460), which was omitted at the discretion of the local Heart Team if CAD could be effectively ruled out on cCTA (72/460). CT examinations in which CAD could not be ruled out (CAD
RESULTS
ML-based CT-FFR was successfully performed in 79.4% (216/272) of all CAD
CONCLUSIONS
ML-based CT-FFR may further improve the diagnostic performance of cCTA by correctly reclassifying a considerable proportion of patients with morphological signs of obstructive CAD on cCTA during pre-TAVR evaluation. Thereby, CT-FFR has the potential to further reduce the need for ICA in this challenging elderly group of patients before TAVR.

Identifiants

pubmed: 34801449
pii: S1936-878X(21)00697-5
doi: 10.1016/j.jcmg.2021.09.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

476-486

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Mr Panknin is an employee of Siemens Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Robin F Gohmann (RF)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany; Medical Faculty, University of Leipzig, Leipzig, Germany. Electronic address: robin.gohmann@gmx.de.

Konrad Pawelka (K)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany; Medical Faculty, University of Leipzig, Leipzig, Germany.

Patrick Seitz (P)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.

Nicolas Majunke (N)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Linda Heiser (L)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.

Katharina Renatus (K)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany; Medical Faculty, University of Leipzig, Leipzig, Germany.

Steffen Desch (S)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Philipp Lauten (P)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

David Holzhey (D)

Department of Cardiac Surgery, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Thilo Noack (T)

Department of Cardiac Surgery, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Johannes Wilde (J)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Philipp Kiefer (P)

Department of Cardiac Surgery, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Christian Krieghoff (C)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.

Christian Lücke (C)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.

Sebastian Gottschling (S)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.

Sebastian Ebel (S)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany; Medical Faculty, University of Leipzig, Leipzig, Germany.

Michael A Borger (MA)

Department of Cardiac Surgery, Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Leipzig Heart Institute, Leipzig, Germany.

Holger Thiele (H)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Leipzig Heart Institute, Leipzig, Germany.

Christoph Panknin (C)

Siemens Healthcare GmbH, Erlangen, Germany.

Matthias Horn (M)

Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.

Mohamed Abdel-Wahab (M)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Matthias Gutberlet (M)

Department of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany; Medical Faculty, University of Leipzig, Leipzig, Germany; Leipzig Heart Institute, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH